ArticleAddiction (Abingdon, England)2015
Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland.
Article in Addiction (Abingdon, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- The characteristics of residents with unawareness of hepatitis C virus infection in community.PloS one · 2018Trial
- Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.The Lancet regional health. Europe · 2024Article
- Laying the foundations for hepatitis C elimination: evaluating the development and contribution of community care pathways to diagnostic efforts.BMC public health · 2023Review
- Liver function tests in primary care provide a key opportunity to diagnose and engage patients with hepatitis C.Epidemiology and infection · 2022Article
- Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.World journal of gastroenterology · 2022Article
- Evaluating the power of the causal impact method in observational studies of HCV treatment as prevention.Statistical communications in infectious diseases · 2021Article
- Estimating the prevalence of problem drug use from drug-related mortality data.Addiction (Abingdon, England) · 2020Article
- HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection.Viruses · 2020Article
- Article
- Monitoring the hepatitis C epidemic in England and evaluating intervention scale-up using routinely collected data.Journal of viral hepatitis · 2019Article
- Multiple Systems Estimation (or Capture-Recapture Estimation) to Inform Public Policy.Annual review of statistics and its application · 2018Article
- Evidence Synthesis for Stochastic Epidemic Models.Statistical science : a review journal of the Institute of Mathematical Statistics · 2018Article
- Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.Current opinion in infectious diseases · 2015Review
- Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland.Addiction (Abingdon, England) · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsTo estimate the number of people who have ever injected drugs (defined here as PWID) living in Scotland in 2009 who have been infected with the hepatitis C virus (HCV) and to quantify and characterize the population remaining undiagnosed.
methodsInformation from routine surveillance (n=22616) and survey data (n=2511) was combined using a multiparameter evidence synthesis approach to estimate the size of the PWID population, HCV antibody prevalence and the proportion of HCV antibody prevalent cases who have been diagnosed, in subgroups defined by recency of injecting (in the last year or not), age (15-34 and 35-64 years), gender and region of residence (Greater Glasgow and Clyde and the rest of Scotland).
resultsHCV antibody-prevalence among PWID in Scotland during 2009 was estimated to be 57% [95% CI=52-61%], corresponding to 46657 [95% credible interval (CI)=33812-66803] prevalent cases. Of these, 27434 (95% CI=14636-47564) were undiagnosed, representing 59% [95% CI=43-71%] of prevalent cases. Among the undiagnosed, 83% (95% CI=75-89%) were PWID who had not injected in the last year and 71% (95% CI=58-85%) were aged 35-64 years.
conclusionsThe number of undiagnosed hepatitis C virus-infected cases in Scotland appears to be particularly high among those who have injected drugs more than 1 year ago and are more than 35 years old.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.